GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SNDL SNDL · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.40

-1.41%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2025

Revenue

C$946.4m

FY2016FY2025

Net income

−C$15.8m

FY2016FY2025

Free cash flow

C$58.1m

FY2016FY2025

Shareholders' equity

C$1.10bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueC$946.4mC$920.4mC$909.0mC$712.2mC$56.1mC$60.9mC$63.6m—C$9.7m—
Gross profitC$258.6mC$240.3mC$190.4mC$140.4m−C$9.0m−C$49.9mC$36.5m−C$417,141C$366,000—
Research and developmentC$489,000C$346,000C$324,000C$2.4mC$2.4mC$488,000C$2.4mC$14,843C$413,000—
Operating income−C$4.4m−C$103.8m−C$163.2m−C$347.8m−C$134.4m−C$195.4m−C$52.4m−C$1.5m−C$12.9m−C$1.5m
Net income−C$15.8m−C$94.8m−C$172.7m−C$335.1m−C$227.0m−C$233.2m−C$271.5m−C$3.0m−C$13.0m−C$1.5m
Diluted earnings per share-0.06-0.36-0.66-1.46-1.10-4.37-25.46-0.39-0.05-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsC$1.34bnC$1.35bnC$1.47bnC$1.56bnC$1.43bnC$294.9mC$510.0mC$110.2mC$25.8mC$12.7m
Cash and short-term investmentsC$273.2mC$248.9mC$201.6mC$311.8mC$649.0mC$60.4mC$45.3mC$14.1mC$7.7mC$3.7m
Total liabilitiesC$235.0mC$215.9mC$243.8mC$231.7mC$98.1mC$25.2mC$288.8mC$118.1mC$12.0mC$1.1m
DebtC$170.1mC$152.3mC$167.0mC$169.8mC$33.5mC$1.4mC$211.1mC$73.9mC$7.1mC$25,564
Shareholders' equityC$1.10bnC$1.13bnC$1.21bnC$1.31bnC$1.33bnC$271.7mC$216.5m−C$7.9mC$13.7mC$11.5m
Shares outstanding263m263m263m230m206m53m11m8m257m257m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsC$70.9mC$54.9m−C$16.6m−C$6.7m−C$155.4m−C$57.5m−C$112.7m−C$30.9m−C$5.2m−C$1.4m
Capital spending−C$12.8m−C$11.0m−C$7.9m−C$10.9m−C$3.8m−C$3.2m−C$110.3m−C$91.6m−C$7.6m−C$4.8m
Free cash flowC$58.1mC$43.9m−C$24.6m−C$17.6m−C$159.2m−C$60.7m−C$223.0m−C$122.5m−C$12.8m−C$6.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueC$235.8mC$195.9mC$252.5mC$244.2mC$244.8mC$204.9mC$257.7mC$236.9m
Gross profitC$56.3mC$52.8mC$70.2mC$64.2mC$67.6mC$56.6mC$68.8mC$63.0m
Operating income−C$7.4m−C$11.2mC$10.3m−C$9.4mC$2.9m−C$8.2m−C$76.1m−C$18.5m
Net income−C$7.8m−C$9.9mC$9.4m−C$13.3mC$2.9m−C$14.7m−C$67.1m−C$19.3m
Diluted earnings per share-0.03-0.040.04-0.050.01-0.06-0.26-0.07
Cash from operationsC$3.0mC$3.0mC$25.0mC$31.0mC$6.0mC$7.0mC$24.0mC$22.0m
Capital spending−C$1.0m−C$2.0m−C$3.0m−C$5.0m−C$2.0m−C$1.0m−C$3.0m−C$4.0m
Free cash flowC$2.0mC$1.0mC$22.0mC$26.0mC$4.0mC$6.0mC$21.0mC$18.0m
Total assetsC$1.28bnC$1.31bnC$1.34bnC$1.32bnC$1.29bnC$1.31bnC$1.35bnC$1.44bn
Cash and short-term investmentsC$186.6mC$233.9mC$273.2mC$241.3mC$211.7mC$224.3mC$248.9mC$289.3m
DebtC$36.1mC$35.0mC$35.5mC$35.2mC$33.4mC$33.3mC$34.3mC$34.5m
Shareholders' equityC$1.06bnC$1.09bnC$1.10bnC$1.10bnC$1.09bnC$1.10bnC$1.13bnC$1.21bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.9%73.1%—
Operating income-76.7%-53.1%—
Net income-63.9%-41.7%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin26.7%23.8%21.4%—

Valuation history

At each fiscal year end

FY2025
Price to earnings-27.7
Price to sales0.5

Share price return

Finished calendar years

2025
Return7%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 26 Jul 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.